云南白药 (000538)
YUNNAN BAIYAO GROUP CO.,LTD.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 178426.26
- Circulating A-Shares(W): 177279.41
- Earnings Per Share(RMB): 2.6800
- Net Assets Per Share(RMB): 22.2688
- Operating Revenue(W RMB): 3065421.42
- Total Profit(W RMB): 561509.85
- Net Profit Attributable to Parent(W RMB): 477711.97
- Net Profit Growth Rate(%): 10.41
- Weighted Return on Equity(%): 11.9200
- Operating Cash Flow Per Share(RMB): 2.4970
- Undistributed Profit Per Share(RMB): 9.9907
- Capital Reserve Per Share(RMB): 9.9157
2. Main Business
The main business covers:
- Pharmaceuticals
- Health Products
- Chinese Medicine Resources
- Yunnan Provincial Pharmaceutical Company
3. Company Basic Information
- Company Name: Yunnan Baiyao Group Co., Ltd.
- Listing Date: 1993-12-15
- Industry: Pharmaceutical Manufacturing
- Address: No. 3686, Yunnan Baiyao Street, Chenggong District, Kunming City, Yunnan Province, China
- Website: www.yunnanbaiyao.com.cn
- Company Profile: The company's predecessor was Yunnan Baiyao Factory. In May 1993, it began its shareholding system restructuring. Part of the original factory's net assets and the initiators' investments were converted into 40 million state shares, 16 million legal person shares, and 4 million privately placed legal person shares. After the initial public offering in November of the same year, the total number of shares upon listing was 80 million. Employee shares of 1.9812 million were listed for trading on July 11, 1994.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Yunnan Provincial State-owned Equity Operation and Management Co., Ltd. | General Legal Person | 46743.18 | 26.37 |
| 2 | New Huadu Industrial Group Co., Ltd. | General Legal Person | 37974.22 | 21.42 |
| 3 | Yunnan Hehe (Group) Co., Ltd. | General Legal Person | 14618.59 | 8.25 |
| 4 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 6050.77 | 3.41 |
| 5 | New Huadu Group - Guosen Securities - 25 New Huadu EB01 Guarantee and Trust Property Special Account | Asset Management Plan | 5600.00 | 3.16 |
| 6 | China Securities Finance Corporation Limited | Special Legal Person | 3737.31 | 2.11 |
| 7 | Central Huijin Asset Management Co., Ltd. | Special Legal Person | 1661.74 | 0.94 |
| 8 | China Life Insurance Company Limited - Traditional - Ordinary Insurance Product - 005L-CT001 Hu | General Legal Person | 1519.86 | 0.86 |
| 9 | Huatai-PineBridge CSI 300 Exchange Traded Open-End Index Securities Investment Fund | Fund | 1514.50 | 0.85 |
| 10 | E Fund CSI 300 Healthcare Sector Exchange Traded Open-End Index Securities Investment Fund | Fund | 1117.68 | 0.63 |
5. Concept Sectors
- Tongdaxin 88
- Industrial Hemp
- Mask Protection
- Medical Aesthetics Concept
- Innovative Drugs
- Margin Trading & Securities Lending
- Overall Listing
- Large-Cap Stocks
- High-Performance Stocks
- Industry Leader
- Being Subject to a Takeover Bid
- China Securities Finance & Central Huijin
- MSCI Constituent
- Northbound Heavy Holdings
- Non-Cyclical Stocks
- High-Dividend Stocks
- High Accounts Receivable
- CSI 100 Index
- SZSE Value Index
- Large-Cap Value Index
- SZSE Component Index
- SZSE 100 Index
- SZSE 300 Index
- SZSE Dividend Index
- SZSE Corporate Governance Index
- Consumption 100 Index
- SZSE Value Index (National)
- CSI 300 Index
- CCTV 50 Index
- CSI 200 Index
- CSI 300 Non-Cyclical Index
- Investment Clock Index
- CSI 300 ESG Index
- State-Owned Enterprise Reform
- SZSE 50 Index
- SZSE Main Board 50 Index
- Analyst Index
- CSI A100 Index
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information